Logo image of PAVM

PAVMED INC (PAVM) Stock Fundamental Analysis

NASDAQ:PAVM - Nasdaq - US70387R4039 - Common Stock - Currency: USD

0.61  0 (-0.26%)

Fundamental Rating

4

Taking everything into account, PAVM scores 4 out of 10 in our fundamental rating. PAVM was compared to 503 industry peers in the Health Care Equipment & Supplies industry. PAVM has a bad profitability rating. Also its financial health evaluation is rather negative. PAVM is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year PAVM was profitable.
In the past year PAVM has reported a negative cash flow from operations.
In the past 5 years PAVM reported 4 times negative net income.
PAVM had a negative operating cash flow in each of the past 5 years.
PAVM Yearly Net Income VS EBIT VS OCF VS FCFPAVM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M

1.2 Ratios

PAVM's Return On Assets of 137.15% is amongst the best of the industry. PAVM outperforms 100.00% of its industry peers.
PAVM's Return On Equity of 154.17% is amongst the best of the industry. PAVM outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 137.15%
ROE 154.17%
ROIC N/A
ROA(3y)-87.06%
ROA(5y)-98.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PAVM Yearly ROA, ROE, ROICPAVM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

The Profit Margin of PAVM (3635.17%) is better than 100.00% of its industry peers.
The Operating Margin and Gross Margin are not available for PAVM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 3635.17%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PAVM Yearly Profit, Operating, Gross MarginsPAVM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

2

2. Health

2.1 Basic Checks

PAVM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PAVM has been increased compared to 1 year ago.
PAVM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, PAVM has an improved debt to assets ratio.
PAVM Yearly Shares OutstandingPAVM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PAVM Yearly Total Debt VS Total AssetsPAVM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -7.52, we must say that PAVM is in the distress zone and has some risk of bankruptcy.
PAVM has a worse Altman-Z score (-7.52) than 77.01% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that PAVM is not too dependend on debt financing.
PAVM's Debt to Equity ratio of 0.14 is in line compared to the rest of the industry. PAVM outperforms 54.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z -7.52
ROIC/WACCN/A
WACC6.7%
PAVM Yearly LT Debt VS Equity VS FCFPAVM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

A Current Ratio of 0.37 indicates that PAVM may have some problems paying its short term obligations.
The Current ratio of PAVM (0.37) is worse than 95.19% of its industry peers.
A Quick Ratio of 0.37 indicates that PAVM may have some problems paying its short term obligations.
The Quick ratio of PAVM (0.37) is worse than 94.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.37
PAVM Yearly Current Assets VS Current LiabilitesPAVM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

7

3. Growth

3.1 Past

PAVM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 109.85%, which is quite impressive.
The Revenue for PAVM has decreased by -33.98% in the past year. This is quite bad
PAVM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 81.61% yearly.
EPS 1Y (TTM)109.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.98%
Revenue 1Y (TTM)-33.98%
Revenue growth 3Y81.61%
Revenue growth 5YN/A
Sales Q2Q%-99.21%

3.2 Future

PAVM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.12% yearly.
Based on estimates for the next years, PAVM will show a very strong growth in Revenue. The Revenue will grow by 142.05% on average per year.
EPS Next Y72.05%
EPS Next 2Y34.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-96.01%
Revenue Next 2Y-52.94%
Revenue Next 3Y268.29%
Revenue Next 5Y142.05%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PAVM Yearly Revenue VS EstimatesPAVM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
PAVM Yearly EPS VS EstimatesPAVM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -5 -10 -15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

PAVM is valuated cheaply with a Price/Earnings ratio of 0.69.
Compared to the rest of the industry, the Price/Earnings ratio of PAVM indicates a rather cheap valuation: PAVM is cheaper than 99.47% of the companies listed in the same industry.
PAVM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.32.
The Forward Price/Earnings Ratio is negative for PAVM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 0.69
Fwd PE N/A
PAVM Price Earnings VS Forward Price EarningsPAVM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PAVM Per share dataPAVM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PAVM's earnings are expected to grow with 34.12% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y34.12%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PAVM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PAVMED INC

NASDAQ:PAVM (6/18/2025, 4:05:27 PM)

0.61

0 (-0.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)08-11 2025-08-11
Inst Owners7.05%
Inst Owner Change16.61%
Ins Owners5.92%
Ins Owner Change0%
Market Cap10.75M
Analysts82.5
Price Target11.99 (1865.57%)
Short Float %2.56%
Short Ratio2.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)253.15%
Min EPS beat(2)149.88%
Max EPS beat(2)356.41%
EPS beat(4)3
Avg EPS beat(4)124.37%
Min EPS beat(4)-28.52%
Max EPS beat(4)356.41%
EPS beat(8)5
Avg EPS beat(8)57.89%
EPS beat(12)7
Avg EPS beat(12)37.75%
EPS beat(16)7
Avg EPS beat(16)22.99%
Revenue beat(2)0
Avg Revenue beat(2)-59.94%
Min Revenue beat(2)-98.31%
Max Revenue beat(2)-21.57%
Revenue beat(4)0
Avg Revenue beat(4)-37.71%
Min Revenue beat(4)-98.31%
Max Revenue beat(4)-10.67%
Revenue beat(8)1
Avg Revenue beat(8)-26.23%
Revenue beat(12)2
Avg Revenue beat(12)-35.64%
Revenue beat(16)2
Avg Revenue beat(16)-40.39%
PT rev (1m)0%
PT rev (3m)30.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)56.25%
EPS NY rev (1m)0%
EPS NY rev (3m)60.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-72.22%
Revenue NY rev (1m)-3.93%
Revenue NY rev (3m)-98.86%
Valuation
Industry RankSector Rank
PE 0.69
Fwd PE N/A
P/S 5.39
P/FCF N/A
P/OCF N/A
P/B 0.23
P/tB 0.23
EV/EBITDA N/A
EPS(TTM)0.88
EY144.26%
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-1.25
FCFYN/A
OCF(TTM)-1.25
OCFYN/A
SpS0.11
BVpS2.67
TBVpS2.67
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 137.15%
ROE 154.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3635.17%
GM N/A
FCFM N/A
ROA(3y)-87.06%
ROA(5y)-98.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.9%
Cap/Sales 0.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.37
Quick Ratio 0.37
Altman-Z -7.52
F-Score4
WACC6.7%
ROIC/WACCN/A
Cap/Depr(3y)25.15%
Cap/Depr(5y)202.92%
Cap/Sales(3y)138.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.98%
EPS Next Y72.05%
EPS Next 2Y34.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.98%
Revenue growth 3Y81.61%
Revenue growth 5YN/A
Sales Q2Q%-99.21%
Revenue Next Year-96.01%
Revenue Next 2Y-52.94%
Revenue Next 3Y268.29%
Revenue Next 5Y142.05%
EBIT growth 1Y42.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.96%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.64%
OCF growth 3YN/A
OCF growth 5YN/A